{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:55:23Z","timestamp":1790848523375,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,4]],"date-time":"2027-09-04T00:00:00Z","timestamp":1820016000000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG071692"],"award-info":[{"award-number":["R01 AG071692"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jamda.2026.106444","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:33:49Z","timestamp":1788503629000},"page":"106444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geographic Variation of Gabapentinoids and Opioids in US Nursing Homes"],"prefix":"10.1016","volume":"27","author":[{"given":"Heeyoon","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonggyu","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-7747","authenticated-orcid":false,"given":"Kate L.","family":"Lapane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2026.106444_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamainternmed.2019.0086","article-title":"A clinical overview of off-label use of gabapentinoid drugs","volume":"179","author":"Goodman","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2026.106444_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.9043","article-title":"The 2016 CDC Opioid guideline and analgesic prescribing patterns in older adults with cancer","volume":"8","author":"Rodin","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2026.106444_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamainternmed.2022.5268","article-title":"Trends in the concurrent prescription of opioids and gabapentin in the US, 2006 to 2018","volume":"183","author":"Peet","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2026.106444_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1370\/afm.3052","article-title":"Update to gabapentinoid use in the United States, 2002-2021","volume":"22","author":"Johansen","year":"2024","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jamda.2026.106444_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.18626","article-title":"Trends in the use of gabapentinoids and opioids in the postoperative period among older adults","volume":"6","author":"Bongiovanni","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2026.106444_bib8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.7326\/ANNALS-25-01750","article-title":"Trends in dispensed gabapentin prescriptions in the United States, 2010 to 2024","volume":"178","author":"Strahan","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2026.106444_bib9","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1007\/s11606-021-07314-2","article-title":"Association of state-imposed restrictions on gabapentin with changes in prescribing in medicare","volume":"37","author":"Grauer","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jamda.2026.106444_bib10","first-page":"294","article-title":"Medication costs and use of older Americans in assisted living settings: a nationally representative cross-sectional study","volume":"38","author":"Lei","year":"2023","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jamda.2026.106444_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40266-019-00732-2","article-title":"The prevalence and factors associated with antiepileptic drug use in US nursing home residents","volume":"37","author":"Zhao","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106444_bib12","article-title":"A Nursing Home Clinician Survey to explain gabapentinoid increases","volume":"26","author":"Winter","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106444_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/07317115.2024.2379974","article-title":"Understanding long-stay gabapentin use increases: a National Nursing Home Clinician Survey on prescribing intent","volume":"47","author":"Winter","year":"2024","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.jamda.2026.106444_bib14","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/jgs.19381","article-title":"Clinician perspectives on increased gabapentinoid prescribing in nursing homes","volume":"73","author":"Winter","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106444_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MLR.0000000000000972","article-title":"Geographic variation in the initiation of commonly used opioids and dosage strength in United States nursing homes","volume":"56","author":"Hunnicutt","year":"2018","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106444_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jamda.2020.10.001","article-title":"Geographic variation in anticoagulant use and resident, nursing home, and county characteristics associated with treatment among US nursing home residents","volume":"22","author":"Alcusky","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106444_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MLR.0000000000001505","article-title":"Geographic variation of statin use among US nursing home residents with life-limiting illness","volume":"59","author":"Mack","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106444_bib18","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1111\/jgs.17270","article-title":"Geographic variation in influenza vaccination among U.S. nursing home residents: a national study","volume":"69","author":"Silva","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106444_bib19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/MLR.0000000000002016","article-title":"Geographic variation of antidementia and antipsychotic medication use among US nursing home residents with dementia","volume":"62","author":"Rataj","year":"2024","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106444_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/JPR.S345521","article-title":"Geographic variation in the use of gabapentinoids and opioids for pain in a commercially insured adult population in the United States","volume":"15","author":"Zhao","year":"2022","journal-title":"J Pain Res"},{"key":"10.1016\/j.jamda.2026.106444_bib21","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106444_bib22","series-title":"Commissioner O of the. FDA in Brief: FDA Requires New Warnings for Gabapentinoids About Risk of Respiratory Depression","year":"2019"},{"key":"10.1016\/j.jamda.2026.106444_bib27","first-page":"1145","article-title":"The quality of care. How can it be assessed? 1988","volume":"121","author":"Donabedian","year":"1997","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jamda.2026.106444_bib28","series-title":"The Quality of Medical Care in the United States: A Report on the Medicare Program: The Dartmouth Atlas of Health Care 1999","first-page":"289","article-title":"Appendix on the geography of health care in the United States","year":"1999"},{"key":"10.1016\/j.jamda.2026.106444_bib29","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/gps.5516","article-title":"Development and psychometric evaluation of the Social Connectedness Index in nursing home residents with Alzheimer\u2019s disease and dementia using the Minimum Data Set 3.0","volume":"36","author":"Bova","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2026.106444_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000525343","article-title":"Social connectedness among long-stay nursing home residents with Alzheimer\u2019s and dementia: exploring individual and facility-level variation","volume":"51","author":"Lapane","year":"2022","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2026.106444_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jamda.2014.11.018","article-title":"Functional improvement among short-stay nursing home residents in the MDS 3.0","volume":"16","author":"Wysocki","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106444_bib32","doi-asserted-by":"crossref","first-page":"M546","DOI":"10.1093\/gerona\/54.11.M546","article-title":"Scaling ADLs within the MDS","volume":"54","author":"Morris","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2026.106444_bib33","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/MLR.0000000000000334","article-title":"The minimum data set 3.0 cognitive function scale","volume":"55","author":"Thomas","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106444_bib34","first-page":"336","article-title":"Multilevel regression modelling to investigate variation in disease prevalence across locations","volume":"46","author":"Weinmayr","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jamda.2026.106444_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/2042098611406167","article-title":"Pharmacy interventions on prescribing in nursing homes: from evidence to practice","volume":"2","author":"Hughes","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jamda.2026.106444_bib36","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.jamda.2021.04.016","article-title":"State variation in chronic opioid use in long-term care nursing home residents","volume":"22","author":"Mehta","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106444_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/10775587251339917","article-title":"Trends and disparities in the use of opioid, gabapentinoid, and nonpharmacologic pain therapies among medicare beneficiaries with acute low back pain, 2016\u20132019","volume":"82","author":"Vaillant","year":"2025","journal-title":"Med Care Res Rev MCRR"},{"key":"10.1016\/j.jamda.2026.106444_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcot.2025.102924","article-title":"Changes in orthopaedic prescribing patterns of gabapentin associated with state prescribing restrictions: a large database study","volume":"63","author":"Guyler","year":"2025","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.jamda.2026.106444_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/NRL.0000000000000522","article-title":"Trends in antiseizure medication prescribing among nursing home residents with and without a seizure diagnosis","volume":"28","author":"Winter","year":"2023","journal-title":"The neurologist"},{"key":"10.1016\/j.jamda.2026.106444_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2026.106178","article-title":"The prevalence of central nervous system-active polypharmacy in US nursing homes","volume":"27","author":"Jung","year":"2026","journal-title":"J Am Med Dir Assoc"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026003348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026003348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:10:15Z","timestamp":1790845815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861026003348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525861026003348"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106444","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic Variation of Gabapentinoids and Opioids in US Nursing Homes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106444"}}